Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-2506 in Acute Ischemic Stroke
NCT00046761Phase 3Terminated
- Sponsor
- Ono Pharmaceutical
- Start
- Nov 2002
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing ONO-2506 with Placebo (2 arms). Primary endpoint: Modified Rankin Scale. Started Nov 2002; status: terminated.
02
Drugs
arundic acid
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00046761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046761.